Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Doxazosin mesylate
Cat. No.:
OB0225LY-0400
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Doxazosin mesylate is an α1-adrenergic receptor antagonist that has been used primarily to study its role in smooth muscle relaxation and blood pressure regulation.
Synonym:
UK 33274 mesylate; 77883-43-3; Cardura; Carduran; Cardular; Alfadil; Cardenalin; Dedralen; Progandol; Tensiobas; (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone methanesulfonate
CAS No.:
77883-43-3
Compound CID:
62978
Formula:
C24H29N5O8S
Formula Weight:
547.58
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Doxazosin mesylate can be used to study vasodilatory mechanisms or play an important role in hypertension and prostate enlargement research.
Library Information
Targets:
Adrenergic receptor
Receptors:
α1-Adrenergic receptor
Pathways:
Neuronal signaling; Autophagy; GPCR/G protein
Plate Number:
AOCL-6
Plate Location:
b6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 91.31 mM
ALogP:
2.071
HBA_Count:
7
HBD_Count:
1
Rotatable Bond:
4
